Core Points - The 2025 Third Guangdong-Hong Kong-Macao Greater Bay Area Development Business Roundtable Meeting was successfully held in Huizhou on July 22, 2025, with approximately 120 attendees including representatives from 57 member units and special guests [1][3] - The meeting aimed to enhance communication and cooperation among businesses in the Greater Bay Area, focusing on high-quality development and rule alignment [3][4] - Huizhou is committed to high-quality development and aims to become a new growth pole in Guangdong, leveraging its industrial platform, transportation system, and innovation capabilities [6][10] Group 1 - The roundtable meetings have been held four times since their inception in 2024, significantly promoting collaboration among businesses in the region [3][4] - The meeting included a special inspection of the business environment, allowing representatives to experience the industrial ecosystem of a "trillion-level economy" [3][4] - The roundtable discussions focused on technology innovation and industrial cooperation, proposing a collaborative innovation system involving government, enterprises, universities, and financial institutions [7][9] Group 2 - Various speakers emphasized the need for a coordinated approach to enhance the supply chain and optimize regional division of labor, particularly in manufacturing and brand operations [7][9] - The meeting highlighted the importance of breaking down institutional barriers and improving cooperation mechanisms to facilitate cross-border e-commerce and international market expansion [7][9] - Companies like Minhua Furniture and Guangdong Zhouming Energy Technology showcased their successful business models and strategies for high-quality development, emphasizing innovation and supply chain optimization [9][10] Group 3 - The successful hosting of the Huizhou roundtable reflects the strong willingness and vitality of the business communities in the three regions to deepen cooperation and seek common development [10][12] - Future plans include the third Guangdong-Hong Kong-Macao Greater Bay Area Development Business Conference scheduled for mid-September 2025 in Guangzhou, aimed at consolidating and expanding the positive momentum [10][12] - The ongoing roundtable meetings are expected to further deepen rule alignment and industrial collaboration, fostering a culture of openness and inclusivity in the Greater Bay Area [12]

Core Themes - The third China International Supply Chain Promotion Expo (Chain Expo) was held in Beijing, focusing on six major chains including advanced manufacturing, clean energy, smart automotive, digital technology, health living, and green agriculture [1] - Over 650 enterprises and institutions from 75 countries and regions participated, with foreign exhibitors accounting for 35% [1] Company Highlights - Yiling Pharmaceutical showcased its achievements in promoting high-quality development in traditional Chinese medicine (TCM) through solidifying the industrial chain, activating the innovation chain, and extending the health chain [3] - Yiling Pharmaceutical emphasized strict quality control of Chinese medicinal materials, establishing over 60 cultivation bases across the country, which also helps local farmers increase their income [4] - The company presented patented new drugs and innovative products in the health sector, including the Ba Zi Bu Shen capsule, which focuses on anti-aging applications [4] - Yiling Pharmaceutical aims to enhance the internationalization of TCM, with a product distribution map covering over 50 countries and regions [5] Industry Innovations - Guangzhou Pharmaceutical Group, the first TCM company to enter the Fortune Global 500, demonstrated its innovative practices in the TCM supply chain through a digital ecosystem, research innovation, and smart logistics [6] - The group has established nearly 90 standardized planting bases and has implemented blockchain technology for traceability and quality control, achieving a 148% increase in production capacity and a 289% increase in efficiency [6] - Sanofi highlighted its 30 years of localization in China, showcasing its high-quality manufacturing capabilities and a comprehensive immunization service chain [7][8] - GE Healthcare presented its latest high-end medical equipment and announced the establishment of a green supply chain innovation ecosystem alliance to promote sustainable practices in the medical device industry [9] - Steady Medical emphasized its commitment to reducing environmental pollution and introduced a new series of medical beauty products aimed at protecting public health [10]

Group 1 - The conference "Advancing Together, Expanding the Future" organized by Beijing Tongrentang Commercial Investment Group aims to enhance collaboration in the traditional Chinese medicine industry, focusing on policy trends, market opportunities, and challenges [1] - The Vice President and General Manager of Beijing Tongrentang Group, Di Shubing, emphasized the need for close cooperation and deep integration among upstream and downstream enterprises in the pharmaceutical industry for high-quality development [1] - The group plans to focus on three main areas: promoting ecological integration, accelerating industrial structure upgrades, and assisting the transformation of time-honored brands to drive high-quality development in the traditional Chinese medicine sector [1] Group 2 - Wang Ping, Vice President and General Manager of Beijing Tongrentang Commercial Investment Group, presented the achievements of the first half of 2025, highlighting collaboration results, store revitalization, training empowerment, product strength enhancement, and scenario-based displays [2] - The company will continue to implement its guiding principles of "integration empowerment, transformation and upgrading, diversified integration, and breakthrough development" in the second half of 2025, focusing on the transformation of "four new" areas: new products, new retail, new medical services, and new business formats [2] - A strategic cooperation agreement was signed between Beijing Tongrentang Commercial Investment Group and Beijing Tongren Medical Technology during the conference, aiming to meet the growing health demands of the public [2]

Core Viewpoint - The third China International Supply Chain Promotion Expo highlights the importance of industrial collaboration and international cooperation, showcasing innovative developments in the supply chain sector [1] Group 1: Innovation and Development Model - Yiling Pharmaceutical has established a unique "theory-clinical-research-industry-education" innovation development model, which integrates traditional Chinese medicine theory with clinical practices and research [1] - The company has undertaken over 60 national and provincial-level projects and holds more than 800 domestic and international patents, demonstrating its commitment to innovation [1] Group 2: Evidence-Based Research - Yiling Pharmaceutical is a pioneer in conducting internationally recognized evidence-based medical research, completing over 40 studies that are among the highest in quantity and quality in the industry [2] - Significant breakthroughs have been achieved in cardiovascular disease prevention, with studies showing a 41% reduction in diabetes risk and a 36% reduction in adverse cardiovascular events [2] Group 3: International Recognition - Research on Yiling's Qi Li Qiang Xin capsules published in the journal Nature Medicine indicates a 22% reduction in major composite endpoint events for heart failure patients [3] - The efficacy of the company's products is gaining international recognition, transitioning traditional Chinese medicine from "experience-based" to "evidence-based" practices [3] Group 4: Health Product Development - Yiling Pharmaceutical's health products, including anti-aging solutions, have attracted attention at the expo, showcasing the integration of technology in traditional medicine [4] - The company has developed over ten proprietary sub-health management products and has a pipeline of more than a hundred product concepts, catering to various health needs [5] Group 5: Market Response - Domestic and international customers have praised Yiling Pharmaceutical's series of health products, indicating strong market interest and acceptance [6]

Core Viewpoint - The article highlights the efforts of Yangtze River Pharmaceutical Group in promoting the standardized cultivation of Zhi fruit (枳壳) in Yuanjiang, Hunan, enhancing local agricultural development and product quality through collaboration and technological innovation [1][4]. Group 1: Company Initiatives - Yangtze River Pharmaceutical Group has established a standardized cultivation base for Zhi fruit in collaboration with local partners, aiming to transform local natural resources into high-quality products [1][2]. - The company emphasizes quality control by sending Zhi fruit for third-party testing, ensuring compliance with standards, which is crucial for brand building [2][3]. - The cultivation area for Zhi fruit has expanded from over 200 acres to more than 1,000 acres, with an annual production capacity exceeding 5,000 tons [4]. Group 2: Technological Advancements - Yangtze River Pharmaceutical Group has developed 81 management documents and 12 specific management files for Zhi fruit cultivation, enhancing quality from the source [3]. - The company utilizes digital technology to establish a transparent and traceable quality management system, improving efficiency and accuracy in the inspection of traditional Chinese medicine [3]. - Automation and intelligent systems are being integrated into the production process, enhancing the stability of product quality [3]. Group 3: Industry Impact - The stable demand from Yangtze River Pharmaceutical Group encourages local farmers to cultivate Zhi fruit, thereby boosting rural economic development [4]. - The local government has set a target to add 1 million standardized Zhi fruit plants by the end of 2029, with an annual increase of 200,000 plants, indicating a strong commitment to industry growth [4].

Core Insights - The article highlights the significant growth and development of the Qichun County's Qiai industry, emphasizing its transformation into a key economic driver and cultural symbol for the region [1][7]. Industry Overview - Qichun County's Qiai industry cluster has achieved a comprehensive output value of 16.306 billion yuan in 2024, marking a year-on-year growth of 27.12% and establishing itself as a provincial key industry cluster with over 4,000 enterprises [1][7]. - The Qiai industry has attracted over 30,000 jobs across the entire industry chain, contributing to local economic development [1][4]. Cultural Significance - Qichun County is recognized as "China's Ai Capital," with deep cultural roots linked to traditional Chinese medicine and the legacy of the famous physician Li Shizhen [1][2]. - The design of Qichun South Station reflects local cultural elements, enhancing the region's identity as a hub for traditional medicine and tourism [1]. Entrepreneurial Spirit - Local entrepreneurs, such as Chen Zhixiang and Xiao Benda, embody a "craftsman spirit," focusing on traditional handcrafting methods and innovative product development within the Qiai industry [2][4][6]. - The industry has seen a rise in new market participants, with over 1,500 new entities established in the past three years, indicating a vibrant entrepreneurial ecosystem [6]. Market Expansion - The demand for Qiai products has grown at an annual rate exceeding 20% over the past decade, with market expansion reaching international markets including the USA, UK, France, and Australia [7]. - Qichun has implemented digital marketing strategies, including establishing a live-streaming base and e-commerce platforms, resulting in online sales of Qiai products reaching 5.7 billion yuan in 2024 [7][8]. Tourism Development - The integration of cultural tourism with the Qiai industry has led to the development of a modern industrial matrix, enhancing the region's appeal as a tourist destination [8][10]. - During the recent May Day holiday, Qichun County welcomed over 250,000 tourists, reflecting a 23.1% increase in tourism revenue, which reached 167 million yuan [8].

Core Viewpoint - The rapid growth of digital technology in the healthcare sector is driving the development of digital traditional Chinese medicine (TCM), which has become a national strategy in China [1] Group 1: Policy and Strategic Initiatives - The National Administration of Traditional Chinese Medicine and the National Data Bureau issued a notice to promote the integration of big data and artificial intelligence into TCM over the next 3-5 years [1] - The initiative aims to create a "smart TCM" system that supports the modernization of TCM and contributes to the construction of a digital China [1] Group 2: Implementation in Dongying City - Dongying City is actively responding to national policies by focusing on the multiplier effect of data elements and exploring the value of TCM data to enhance high-quality development [1] - A city-wide TCM diagnosis and treatment business supervision system has been established to collect and analyze data from various medical institutions, providing a scientific basis for performance management [1] Group 3: Innovations in TCM Services - Five smart shared TCM pharmacies have been established, allowing grassroots medical institutions to prescribe, process, and deliver TCM, achieving full coverage in the region [2] - By June 2025, these pharmacies had completed over 490,000 TCM prescriptions and delivered over 150,000 orders, significantly improving resident satisfaction and medical experience [2] Group 4: Digital Health Services - The "Dongying Famous Doctors Hall" platform integrates online and offline TCM services, enabling residents to access expert consultations and services from home [3] - The implementation of the "one-stop service" for TCM prescriptions has streamlined the management of TCM services, enhancing the overall patient experience [3]

Core Viewpoint - Traditional Chinese medicine offers various methods to help individuals quit smoking by addressing both the symptoms and underlying issues related to smoking addiction [1][6]. Group 1: Methods for Quitting Smoking - **Tea Replacement**: Drinking herbal teas such as green tea, mint, or licorice can help clear lung energy and reduce cravings. For those with weak stomachs, red tea can be used instead [1]. - **Herbal Decoction**: A combination of herbs like purple aster, winter flower, and loquat leaves can be used to alleviate symptoms such as cough and phlegm associated with smoking [2][3]. - **Herbal Patches**: Applying a patch made from herbs like cinnamon and clove can help reduce cravings and anxiety when used consistently over time [4]. - **Aromatherapy**: Carrying mugwort sticks and inhaling their aroma can create an aversion to the smell of cigarettes, aiding in the quitting process [5]. - **Acupuncture**: Stimulating specific ear points related to lung and bronchial health can help decrease the desire to smoke [5]. Group 2: Health Risks of Smoking - **Chemical Exposure**: Smoking releases over 7,000 chemicals, with nicotine acting as a highly addictive substance that affects the brain's reward system [6]. - **Cancer Risk**: Smokers are 23 times more likely to develop lung cancer compared to non-smokers, and the incidence of coronary heart disease increases by 2-4 times [6]. - **Secondhand Smoke Effects**: Children exposed to secondhand smoke face a 6-fold increase in respiratory infections and a 3-fold increase in asthma rates [6].

Group 1 - The project involves the establishment of a Traditional Medicine Center in Astana, Kazakhstan, by Xi'an Traditional Chinese Medicine Brain Disease Hospital, supported by China Export & Credit Insurance Corporation (Sinosure) [1][2] - This center is the first demonstration project of traditional medicine cooperation between China and Kazakhstan, contributing to the high-quality development of the Belt and Road Initiative and the internationalization of Chinese medicine [1] - The center focuses on acupuncture, massage, and cupping therapies, combined with modern rehabilitation techniques, providing services for brain disease treatment, chronic disease management, and health care, with over 38,000 patients treated [1] Group 2 - Sinosure has tailored an overseas investment insurance plan for the project, offering 10 years of political risk coverage against war, expropriation, and currency exchange restrictions, ensuring stable operation of the project [1] - The insurance policy alleviates concerns for private institutions venturing abroad, supporting the sustainable development of Chinese medicine services overseas and providing high-quality rehabilitation medical services to the Central Asian population [1] - The initiative aligns with President Xi Jinping's directive to establish more traditional medicine centers in Central Asia, demonstrating Sinosure's commitment to supporting the internationalization of the private economy [2]

Group 1 - The sixth China (Gansu) Traditional Chinese Medicine Industry Expo will be held from August 23 to 25 in Longxi County, Dingxi City, Gansu Province [1] - The theme of the expo is "Inheritance, Innovation, Open Sharing, Promoting High-Quality Development of Traditional Chinese Medicine," focusing on marketization, specialization, and internationalization [2] - The expo will feature 10 activities, including an opening ceremony, policy interpretation, and forums on various topics related to the development of traditional Chinese medicine [2] Group 2 - Gansu Province is a significant birthplace of traditional Chinese medicine and aims to build a trillion-yuan industry cluster, with the total scale of the traditional Chinese medicine industry chain expected to reach 97.2 billion yuan in 2024 [3] - The province's traditional Chinese medicine resources are characterized by high quality and rich variety, with a stable planting area of over 2 million acres and a total output of 500,000 tons, ranking first among prefecture-level cities in China [2] - Key traditional Chinese medicinal materials such as Angelica, Astragalus, and Codonopsis have significant planting areas, accounting for 60%, 40%, and 20% of the national total, respectively [2]